High blood pressure medication voluntarily recalled: FDA
Share
High blood pressure medication voluntarily recalled: FDA
Updated: 2025-12-06T13:01:37Z
High Blood Pressure Medication Voluntarily Recalled: FDA
The Food and Drug Administration (FDA) has announced a voluntary recall of several high blood pressure medications due to potential contamination issues. The move affects thousands of patients taking these medications, which are used to treat hypertension.The affected products contain valsartan, an ingredient that helps lower blood pressure in the body. However, it was discovered that certain lots of the medication contained N-nitrosodimethylamine (NDMA), a known carcinogen.
The FDA stated that while taking these medications may not pose an immediate health risk, long-term consumption could potentially increase cancer risk. Patients are advised to consult their healthcare providers about alternative treatments or options.
For those looking for natural ways to manage blood pressure, our High Frequency Red Blood Vessel Vascular Removal 60W RF Facial Cleaner Beauty Machine has shown promising results in reducing facial veins and improving overall skin health.
- The recall affects the following medication lots:
- Distribution dates: April 2018 to June 2019
- Manufacturers involved:
- Sandoz Inc.
- Mylan Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
The FDA encourages patients and healthcare providers to review the affected medication lots on their website. Stay tuned for further updates as this situation develops.